PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

Anticonvulsants and suicidality, cont'd



Beck and Herrmann, blogging on the same New York Times story we did, raise a fascinating point about the possible tendency of drug trials to generate false positives as to a risk of suicidality. No matter what a drug's actual effects, they say, there may be reason to "expect more reports of suicidal behavior in the drug group than in the placebo group".

 

 


Rafael Mangual
Project Manager,
Legal Policy
rmangual@manhattan-institute.org

Katherine Lazarski
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.